This article is more than 5 years old. Information may no longer be current.
Joint registry launched to monitor TAVR outcomes
The American College of Cardiology and Society of Thoracic Surgeons have launched the joint TVT Registry to monitor real-world outcomes related to the safety and efficacy of transcatheter aortic valve replacement therapy.
The TVT Registry will serve as the main repository for all clinical data related to transcatheter aortic valve replacement (TAVR). It is also positioned to incorporate additional catheter-based procedures that are not marketed in the United States. The registry will also be linked to the Social Security Death Master File and CMS databases to track long-term outcomes.
|
|
According to Michael J. Mack, MD, FACC, president of the Society of Thoracic Surgeons, the registry will not only offer insight into clinical practice patterns and patient outcomes, but will also optimize “patient safety and ensure the appropriate use of TAVR therapy.”
“The TVT Registry will provide an ideal mechanism for monitoring the use of transcatheter valve therapy,” David R. Holmes, Jr., MD, FAAC, ACC president, said in the press release. “The registry can provide relatively rapid feedback to individual sites and help identify trends in its usage … [and] will also provide a rich source of data for long-term research.”
To facilitate accurate and reliable data collection, the ACC and Society of Thoracic Surgeons will sponsor educational opportunities and events for data managers, such as webinars and conference calls. In addition, participating hospitals will receive quarterly reports comparing an institution’s procedure performance with that of the national experience. The registry measures will also look at patient risk factors to adjust for case-mix and adverse event rates.
For more information or additional resources, visit tvtregistry.org.
 |
Follow CardiologyToday.com on Twitter. |